Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Achieved $60.1 million in RYTELO® (imetelstat) net product revenue in Q3 2026, an increase of 5% compared to Q2 2026
Newswire
Achieved $60.1 million in RYTELO® (imetelstat) net product revenue in Q3 2026, an increase of 5% compared to Q2 2026
Financial infrastructure company also appoints Benedict Kelly as Chief Product Officer and names Peter Daunton as Chief Strategy Officer NEW YORK,…
Raises Fiscal Year 2026 Outlook Across Key Metrics on Strong Operational Performance
•Biologics License Application for sonelokimab submitted to the U.S. Food and Drug Administration for the treatment of adults and adolescents with…
The Institute for Financial Integrity (IFI) is pleased to announce that Qi Card, one of Iraq's leading electronic payment companies, is expanding its…
Prevention approach aims to keep patients on immune checkpoint inhibitor (ICI) therapy and avoid immunosuppressive irEC treatments, representing an…
PKF Investment Banking, the investment banking affiliate and subsidiary of PKF O'Connor Davies, one of the nation's largest accounting, tax and…
Revenues for the quarter ended September 30, 2026 total $3.7 billion, pretax income is $112 million, and net income is $59 million Adjusted EBITDA is…
DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the…
24X data, already used by institutions including Crédit Agricole CIB, is also now available through DIGITEC's D3 DataHub HAMILTON, Bermuda, Nov. 4,…
Marriott Vacations Worldwide Reports
Additional analyses from the Phase 2a induction period for OD-001 further strengthen clinical proof of concept in ulcerative colitis